Lili Shen,Chao Li,Jingwen Wang,Jin Fan,Ji Zhu. CEA levels predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Oncol Transl Med, 2022, 8: 180-185.
CEA levels predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Received:January 05, 2022  Revised:July 30, 2022
View Full Text  View/Add Comment  Download reader
KeyWord:locally advanced rectal cancer (LARC); carcinoembryonic antigen (CEA); neoadjuvant chemoradiotherapy; pathological complete response (pCR)
Author NameAffiliationE-mail
Lili Shen Department of Oncology, Nantong Haimen People’s Hospital, Haimen Hospital of Nantong University shenlilimao2012@163.com 
Chao Li Department of Radiotherapy, Huashan Hospital, Fudan University  
Jingwen Wang Department of Radiation Oncology, Fudan University Shanghai Cancer Center  
Jin Fan Department of Radiation Oncology, Fudan University Shanghai Cancer Center  
Ji Zhu Department of Radiation Oncology, Fudan University Shanghai Cancer Center  
Hits: 1865
Download times: 2250
Abstract:
      Objective The aim of this study was to evaluate the impact of serum carcinoembryonic antigen (CEA) in the prediction of pathological complete response (pCR) in locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemoradiotherapy (nCRT). Methods A total of 925 LARC patients who underwent nCRT followed by TME between March 2006 and February 2018 were enrolled at Fudan University Shanghai Cancer Center. Using logistic regression models, we investigated the associations between serum CEA levels and pathological complete remission (pCR). Further stratified analyses were performed according to different CEA thresholds. Results We found that pre-nCRT CEA and post-nCRT CEA were negatively correlated with pCR (P < 0.001). Stratified analyses revealed that when the CEA cutoff value was set to 5 ng/mL, 10.6% of patients with post-nCRT CEA levels > 5 ng/mL achieved pCR. Meanwhile, when the CEA cutoff value was set to 10 ng/mL, only 6.8% of the patients with post-nCRT CEA levels > 10 ng/mL achieved pCR. Conclusion In summary, pre- and post-nCRT CEA levels ≤ 5 ng/mL were favorable predictors of pCR in LACR patients, and the “watch and wait” strategy is not recommended for patients with post-nCRT CEA levels > 10 ng/mL.
Close